SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Josephine Baker — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJosephine Baker
Date of birth1906-06-03
IdentifiersMRN HR-ML049-SYN-TD; SSN (made up) 000-49-3172
Document date1969-05-26
AuthorColette Ashby-Nwosu, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week review after the change to clopidogrel. [S]

History of Present Illness

Ms. Baker returns four weeks after ticagrelor was changed to clopidogrel. She took the loading dose as written, and within a week the episodes of air hunger stopped. She has completed ten cardiac rehabilitation sessions, now walks on the treadmill for 30 minutes at a brisk pace, and has begun light stretching and dance steps with the physiotherapist's approval. Her home blood pressure averages 124/76 on lisinopril 10 mg. She did not have the blood tests ordered for one to two weeks after the last visit (potassium, creatinine and lipids): the order went to the clinic laboratory, and she did not have a ride on the days it was open. She has had no lightheadedness, cough or bleeding. She met the social worker, who is helping her plan the repayment of her debts. She feels more like herself. [S]

ElementDetail
BreathlessnessResolved within a week of stopping ticagrelor
RehabilitationTen sessions; 30 minutes brisk treadmill walking
Home blood pressureAverage 124/76 mmHg
Missed testsMetabolic panel and lipid panel ordered for one to two weeks after the last visit not done; no ride to the clinic laboratory
Seattle Angina Questionnaire-784, from 70

Review of Systems

SystemResultFinding
RespiratoryNegativeNo air hunger or breathlessness; no cough
CardiovascularNegativeNo chest pain, palpitations or lightheadedness
Hematologic/lymphaticNegativeNo bleeding or unusual bruising

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24activeS
Ticagrelor 90 mg oral tablet, one tablet twice dailyOne tablet twice dailyOral route1969-03-24 to 1969-04-28completedS
Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet dailyOne tablet daily after a 600 mg loading doseOral route1969-04-28activeS
Atorvastatin 80 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24activeS
Lisinopril 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-03-24 to 1969-04-28completedS
Lisinopril 10 mg oral tablet, one tablet dailyOne tablet dailyOral route1969-04-28activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route1969-03-24activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1969-05-26Body height168cmS
1969-05-26Body weight59.9kgS
1969-05-26Body mass index (BMI) [Ratio]21.2kg/m2S
1969-05-26Systolic blood pressure126mm[Hg]S
1969-05-26Diastolic blood pressure78mm[Hg]S
1969-05-26Heart rate60/minS
1969-05-26Respiratory rate14/minS
1969-05-26Body temperature36.6CelS
1969-05-26Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1969-05-26Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1969-05-26Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
1969-05-26Creatinine [Mass/volume] in Serum or Plasma0.88mg/dL0.59-1.04 mg/dLNormalS
1969-05-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M74mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1969-05-26Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
1969-05-26Overall summary score [SAQ]84{score}S

Physical Exam

Vital signs recorded on 1969-05-26; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 126/78, pulse 60; weight 59.9 kg
CardiovascularRegular rhythm; no murmur
RespiratoryClear
ExtremitiesNo edema

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning)resolvedconfirmed R06.09S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology attributed it to ticagrelor.
Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1912activeconfirmed I25.10S — Synthetic modern diagnosis; the 1969 heart attack remains D in the history.
High blood pressure, found during the hospital stay for the heart attackactiveconfirmed I10S — Synthetic modern diagnosis; no claim about her real blood pressure.
Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular riskactiveprovisional Z90.710S — Synthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source.
Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrelresolvedconfirmed T45.525AS — Synthetic diagnosis at the second visit; resolved at the third visit after the switch.
Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factoractiveconfirmed E78.41S — Synthetic result measured once at the second visit.
Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recoversactiveconfirmed Z59.86S — Synthetic social need anchored to her documented debts and the loss of Les Milandes.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure (seated, average of two readings; home readings)Every visitCompleted today126/78 mmHg; home average 124/76
ExaminationWeight, BMI and physical activityEvery visitCompleted today59.9 kg; ten rehabilitation sessions, 30 minutes brisk walking
Medication safetyAdherence: aspirin and P2Y12 inhibitor through the dual antiplatelet window, high-intensity statin, beta-blocker, ACE inhibitorEvery visitCompleted todayNo missed doses of aspirin, clopidogrel, atorvastatin, metoprolol or lisinopril
Medication safetyBleeding on dual antiplatelet therapy (symptoms, hemoglobin when indicated)Every visitCompleted todayNo bleeding or bruising
LaboratoryMetabolic panel (potassium, creatinine, eGFR) on an ACE inhibitorOne to two weeks after a start or dose change, then every six to twelve monthsDeferredThe panel due one to two weeks after lisinopril was raised to 10 mg was missed: the order went to the clinic laboratory and she had no ride on its opening days. It was drawn today, four weeks after the change: potassium 4.7 mmol/L and creatinine 0.88 mg/dL (eGFR 74), so no harm resulted. Corrective action: laboratory tests drawn at the rehabilitation center on session days
LaboratoryMetabolic panel (potassium, creatinine, eGFR) on an ACE inhibitorOne to two weeks after a start or dose change, then every six to twelve monthsCompleted todaySodium 140, potassium 4.7, creatinine 0.88 mg/dL (eGFR 74), glucose 92
LaboratoryLipid panelFour to eight weeks after a statin start or change, then every three to twelve monthsDeferredThe panel due four to eight weeks after the statin start was missed with the same laboratory trip and, by oversight, was not added to today's blood test. Corrective action: added to the standing order at the rehabilitation center and to the twelve-week review; harm is judged on that result
SurveyAngina status (Seattle Angina Questionnaire-7)At intake and every few months in the first yearCompleted today84, from 70
SurveyDepression screen (PHQ-2, then PHQ-9)After the infarction and periodicallyUp to datePHQ-9 7 at intake; repeat at about twelve weeks
ImagingEchocardiogram for left ventricular functionAfter the infarction if not done or if function was reduced; then only with clinical changeNot indicatedEjection fraction 52% five weeks after the infarction; no clinical change
ExaminationECG and troponinOnly with new or changing symptomsNot indicatedNo new symptoms
ReferralCardiac rehabilitationWithin weeks of the infarction; 36 sessionsCompleted todayTen of 36 sessions completed
Self-managementSelf-management: chest-pain action plan, nitroglycerin, women's warning symptomsEvery visitCompleted todayAction plan reviewed; nitroglycerin not needed
Medication safetyMedicine and visit costsEvery visitCompleted todayGeneric medicines in 90-day fills; social worker helping with a repayment plan

Goal progress:

Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes (2025); Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and acute myocardial infarction monographs (2026)

Follow-up: Twelve-week review in eight weeks with an exercise test, a lipid panel and a PHQ-9, drawn and done at the rehabilitation center where possible. Call 911 for chest pain not relieved five minutes after one nitroglycerin. Next scheduled visit 1969-07-21: twelve-week review: exercise test, lipids, mood, and the return to performing. [S]